Abstract
Background:RTX-GRT7039 (resiniferatoxin; RTX), is a potent and selective agonist of the transient receptor potential vanilloid 1 (TRPV1) being developed for treatment of pain related to knee osteoarthritis (KOA). RTX-mediated activation...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have